Overview

Test Name

Brugada Syndrome -Expanded Panel

Test Code

CAE1003

Test Category

Gene Panels

Test Subcategory

Cardiology

Disease(s) Targeted

Brugada Syndrome

Who Is The Test For?

Patients with a family history, clinical suspicion, or diagnosis of Brugada Syndrome.

Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis

No. Of Genes

Panel Content

ANK2, CACNA1C, CACNB2, GPD1L, HCN4, KCND3, KCNE3, KCNH2, SCN1B, SCN2B, SCN3B, SCN5A, TRPM4

Mitochondrial Genome Included In The Analysis

Deliverables

Clinical Report (Download a sample report here)

Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

Alternative Panels Available

This is the expanded panel for Brugada Syndrome. We also offer a core panel which includes 11 less genes (2 genes in total). See test details for the Brugada Syndrome - Core Panel.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Brugada Syndrome

Brugada syndrome is an inherited arrhythmic disease associated with ventricular fibrillation (VF), premature sudden arrhythmic death syndrome, and aborted sudden cardiac death (SCD). The genetic basis for Brugada syndrome may be identified in some incidences.